Aviation Medication Transparency Act of 2025
Aviation Medication Transparency Act of 2025
Plain Language Summary
# Aviation Medication Transparency Act of 2025 - Summary **What the Bill Does** The Aviation Medication Transparency Act of 2025 would require greater disclosure of medication information related to aviation safety. While specific provisions aren't detailed in the available information, the bill's title suggests it aims to increase transparency around how medications are handled, reported, or disclosed in the aviation industry—likely addressing concerns about pilot medication use, medication safety protocols, or reporting requirements for airlines and aviation personnel. **Who It Affects** This bill would primarily impact pilots, airline crews, aviation medical examiners, and airlines themselves. It could also affect passengers indirectly if it changes how airlines manage medication-related safety protocols or crew medical certifications. **Current Status** As of now, HR 2592 is in committee, meaning it has been introduced but has not yet been debated or voted on by the full House of Representatives.
The bill was sponsored by Representative Sean Casten (D-IL). Without access to the detailed legislative text, the exact provisions and implementation details cannot be specified, but interested parties can track its progress through Congress.gov for updates.
Latest Action
Referred to the House Committee on Transportation and Infrastructure.